Market Movers (8-K)
See all →Aimfinity Investment Corp. I supplements its proxy statement with new independent director nominees and reports initial product shipments for Docter Inc.
Aimfinity Investment Corp. I has extended its deadline to complete an initial business combination by two months, utilizing a promissory note from its sponsor to fund the extensions.
Delay expected
Capital raise
Aimfinity Investment Corp. I secured a one-month extension to March 28, 2026, for its business combination with Docter Inc., funded by a $500 promissory note from its sponsor's designee.
Delay expected
Capital raise
Aimfinity Investment Corp. I has extended its deadline to complete an initial business combination with Docter Inc. to February 28, 2026, via a $500 promissory note from its sponsor's designee.
Worse than expected
Capital raise
Delay expected
Aimfinity Investment Corp. I secured a one-month extension to January 28, 2026, for its business combination with Docter Inc. by depositing $500 into its trust account.
Delay expected
Capital raise
Aimfinity Investment Corp. I secured a one-month extension to complete its business combination with Docter Inc., pushing the deadline to December 28, 2025.
Delay expected
Worse than expected
Capital raise
Quarterly Earnings (10-Q)
See all →Aimfinity Investment Corp. I faces substantial doubt about its ability to continue as a going concern amidst significant shareholder redemptions and repeated delays in its merger with Docter Inc.
Worse than expected
Capital raise
Delay expected
Aimfinity Investment Corp. I reported a substantial decrease in its trust account due to significant shareholder redemptions, extended its business combination deadline with Docter Inc. to October 28, 2025, and disclosed management's doubt about its ability to continue as a going concern.
Worse than expected
Delay expected
Capital raise
Aimfinity Investment Corp. I, a blank check company, reported a substantial decrease in trust account assets, a significant net income decline, and a going concern warning, alongside a Nasdaq delisting and a new related-party acquisition, as it continues to pursue its business combination with Docter Inc.
Worse than expected
Capital raise
Delay expected
Aimfinity Investment Corp. I reports a net income of $902,163 for the nine months ended September 30, 2024, while continuing efforts to finalize its business combination with Docter Inc.
Worse than expected
Delay expected
Capital raise
Aimfinity Investment Corp. I reports a net income of $438,510 for the three months ended June 30, 2024, while continuing its efforts to complete an initial business combination.
Worse than expected
Delay expected
Aimfinity Investment Corp. I reports a net income for Q1 2024 while navigating going concern uncertainties and working towards a business combination with Docter Inc.
Worse than expected
Delay expected
Capital raise
Annual Reports (10-K)
Aimfinity Investment Corp. I amends its charter to extend the period for completing a business combination, allowing for up to nine additional one-month extensions.
Worse than expected
Delay expected
Aimfinity Investment Corp. I has filed an amendment to its annual report to correct a scrivener's error in the certifications related to internal control over financial reporting.
Aimfinity Investment Corp. I's 10-K filing outlines the company's share structure, warrant details, and governance framework as a blank check company.
Worse than expected
Delay expected
Capital raise
Insider Trading (Form 4)
See all →Aimfinity Investment Corp. I supplements its proxy statement with new independent director nominees and reports initial product shipments for Docter Inc.
Aimfinity Investment Corp. I has extended its deadline to complete an initial business combination by two months, issuing a promissory note to its sponsor for funds used in the extensions.
Capital raise
Delay expected
Aimfinity Investment Corp. I has secured a fifth one-month extension to complete its business combination with Docter Inc., pushing the deadline to March 28, 2026, via a $500 promissory note from its sponsor's manager.
Worse than expected
Capital raise
Delay expected
Aimfinity Investment Corp. I secured a one-month extension to complete its business combination with Docter Inc., pushing the deadline to February 28, 2026.
Delay expected
Capital raise
Aimfinity Investment Corp. I has extended its deadline to complete an initial business combination with Docter Inc. by one month to January 28, 2026, through a $500 payment.
Worse than expected
Capital raise
Delay expected
Aimfinity Investment Corp. I has extended its deadline to complete an initial business combination with Docter Inc. to December 28, 2025, utilizing the first of nine possible monthly extensions.
Delay expected
Capital raise
Proxy Statements (Def-14A)
See all →Aimfinity Investment Corp. I issued a Form 8-K to clarify redemption procedures for its upcoming Extraordinary General Meeting, addressing shareholder inquiries regarding the Docter Business Combination.
Delay expected
Aimfinity Investment Corp. I seeks shareholder approval to extend its business combination deadline to July 28, 2026, and waive the net tangible asset requirement to facilitate the Docter Inc. merger.
Delay expected
Worse than expected
Capital raise
Aimfinity Investment Corp. I is seeking shareholder approval for a business combination with Docter Inc., a health monitoring technology company, in a deal valued at $60 million.
Capital raise
DEFA14A: Aimfinity Investment Corp. I Revises Trust Account Contribution for Charter Amendment Proposal
Aimfinity Investment Corp. I announces revisions to the terms and conditions of its Charter Amendment Proposal, including an adjustment to the required contribution to the trust account for each monthly extension.
Delay expected
Aimfinity Investment Corp. I has adjourned its extraordinary general meeting to January 9, 2024, and extended the deadline for shareholders to deliver redemption requests to January 8, 2025.
Delay expected
Aimfinity Investment Corp. I is requesting shareholder approval to amend its charter, extending the deadline to complete a business combination and allowing for further extensions.
Delay expected
Capital raise
Schedule 13G - Passive Investments
See all →Harraden Circle Investments and related entities have filed an amendment to their Schedule 13G, indicating they no longer beneficially own more than 5% of Aimfinity Investment Corp. I's Class A Common Stock.
Worse than expected
Hudson Bay Capital Management LP and Sander Gerber report 0% beneficial ownership in Aimfinity Investment Corp. I Class A Ordinary Shares.
Worse than expected
Polar Asset Management Partners Inc. has reported a beneficial ownership of 10.6% in Aimfinity Investment Corp. I, holding 170,000 Class A ordinary shares.
SCHEDULE 13G/A: Meteora Capital and Vik Mittal Report Zero Beneficial Ownership in Aimfinity Investment Corp. I
Meteora Capital, LLC and its Managing Member, Vik Mittal, have filed an amended Schedule 13G indicating they no longer hold any beneficial ownership in Aimfinity Investment Corp. I as of March 31, 2025.
Worse than expected
SCHEDULE 13G/A: Wolverine Entities Divest Entire Stake in Aimfinity Investment Corp. I, Reporting Zero Beneficial Ownership
Wolverine Asset Management LLC and its affiliated entities have filed an amended Schedule 13G, indicating they no longer hold any beneficial ownership in Aimfinity Investment Corp. I.
Worse than expected
Cowen and Company, LLC has filed an amended Schedule 13G, reporting zero beneficial ownership of Class A ordinary shares in Aimfinity Investment Corp. I as of December 31, 2024.